Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Environ Res ; 212(Pt A): 113142, 2022 09.
Article in English | MEDLINE | ID: mdl-35378123

ABSTRACT

The synergetic effect of estrogens and androgens is known to play a crucial role in the physiopathology of the prostate gland. Bisphenol A (BPA) is an endocrine disrupting compound that can interfere with endocrine hormone functioning and thereby influence prostate development. The objective of this study was to examine the impact on prostate expression of aromatase, 5α-R isozymes, and prostate cancer-related genes of exposure to low doses of BPA from perinatal period to adulthood. Vehicle or BPA (2.5 µg/kg b.w./day) was administered to gestating Wistar rats from gestational day 12 (GD12) to parturition and then to their male pups from postnatal day 1 (PND1) until euthanization on PND90. Their prostate glands were examined by qRT-PCR, Western blot, PCR array, and morphological study. mRNA and protein levels of 5α-R2 were significantly reduced and mRNA and protein levels of aromatase were significantly increased in BPA-treated animals, which also showed modifications of 8 out of the 84 key genes implicated in the development of prostate cancer. Because BPA interferes with genes involved in intraprostatic androgen and estrogen production and others implicated in prostate cancer, research is warranted into the prostate disease risk associated with chronic low-dose BPA exposure throughout life.


Subject(s)
Cholestenone 5 alpha-Reductase , Prostatic Neoplasms , Adult , Androgens , Animals , Aromatase/genetics , Aromatase/metabolism , Benzhydryl Compounds/toxicity , Cholestenone 5 alpha-Reductase/genetics , Cholestenone 5 alpha-Reductase/metabolism , Humans , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Parturition , Phenols , Pregnancy , Prostatic Neoplasms/chemically induced , Prostatic Neoplasms/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Testosterone/metabolism
3.
Arch Pathol Lab Med ; 144(2): 221-228, 2020 02.
Article in English | MEDLINE | ID: mdl-31295015

ABSTRACT

CONTEXT.­: Complete digital pathology and whole slide imaging for routine histopathology diagnosis is currently in use in few laboratories worldwide. Granada University Hospitals, Spain, which comprises 4 hospitals, adopted full digital pathology for primary histopathology diagnosis in 2016. OBJECTIVE.­: To describe the methodology adopted and the resulting experience at Granada University Hospitals in transitioning to full digital diagnosis. DESIGN.­: All histopathology glass slides generated for routine diagnosis were digitized at ×40 using the Philips IntelliSite Pathology Solution, which includes an ultrafast scanner and an image management system. All hematoxylin-eosin-stained preparations and immunohistochemistry and histochemistry slides were digitized. The existing sample-tracking software and image management system were integrated to allow data interchange through the Health Level 7 protocol. RESULTS.­: Circa 160 000 specimens have been signed out using digital pathology for primary diagnosis. This comprises more than 800 000 digitized glass slides. The scanning error rate during the implementation phase was below 1.5%, and subsequent workflow optimization rendered this rate negligible. Since implementation, Granada University Hospitals pathologists have signed out 21% more cases per year on average. CONCLUSIONS.­: Digital pathology is an adequate medium for primary histopathology diagnosis. Successful digitization relies on existing sample tracking and integration of the information technology infrastructure. Rapid and reliable scanning at ×40 equivalent was key to the transition to a fully digital workflow. Digital pathology resulted in efficiency gains in the preanalytical and analytical phases, and created the basis for computational pathology: the use of computer-assisted tools to aid diagnosis.


Subject(s)
Image Processing, Computer-Assisted/methods , Microscopy/methods , Telepathology/methods , Diagnostic Tests, Routine/methods , Humans , Software , Workflow
4.
Front Nutr ; 6: 192, 2019.
Article in English | MEDLINE | ID: mdl-31998740

ABSTRACT

Thomas Kuhn brings the concept of "paradigm" as the fundamental engine in the progress of humanity. Kuhn defines paradigms as the set of formal theories, experiments and work methods that define a process (scientific, economic, social, and in this case, contemporary haute cuisine), in a given time. According to Kuhn, progress does not happen by gradual accumulation of knowledge, but rather by abrupt advances. In this review, the conceptual evolution experienced by contemporary gastronomy (from the French Revolution to today) is analyzed applying the paradigm structure in light of the scientific knowledge of each era. It is thus reviewed how the first and second gastronomic paradigms, proposed, respectively, by Carême and Escoffier and based on food smell and taste the first and the flavor of the sauces the second, have been replaced by the third and fourth paradigms, led, respectively, by the Nouvelle Cuisine in France and Ferrán Adriá in Spain, and in whose development touch, sight, and sound have become increasingly prominent in gastronomic pleasure. Finally, it is analyzed how new trends in gastronomy: (1) worldwide diffusion of the Spanish tapas; (2) globalization of ethnic and fusion cuisines; (3) the growing disappearance of the professional gastronomic critique and its replacement by mass media influencers; (4) the increase of sustainability in cooking with development of local-, vegan-, and paleo-cooking, comfort, and smart food and finally, (5) the growing role of social networks and the self-itis linked to photography or foodstagramming in the gastronomic experience are leading toward a new gastronomic paradigm based on the global socialization of classic gastronomy.

5.
Histol Histopathol ; 29(5): 601-7, 2014 May.
Article in English | MEDLINE | ID: mdl-24142582

ABSTRACT

UNLABELLED: The aim of this study was to characterize the morphology and immunophenotype of ganglion cysts (GCs) and explore their histogenetic origin. MATERIAL AND METHODS: A cross-sectional morphological and immunohistochemical study of 354 GCs used the following antibody panel: vimentin, specific actin, ß-actin, smooth-muscle actin, smoothelin, h-caldesmon, ß-catenin, desmin, calponin, podoplanin, keratins 5/6, E-cadherin, cyclooxygenase 2 (COX-2), lysozyme, CD10, CD31, CD33, CD34, CD68, Ki-67, and PCNA. Double-blind semi-quantitative analyses were conducted to evaluate the immunopositivity on a 4-point scale. Samples from 10 synovial membranes and 10 scapholunate ligaments were compared. GCs showed a hyalinized wall with mesenchymal spindle cells and were intensely positive for vimentin, actins, h-caldesmon, calponin in all cases and for podoplanin in 53% of cases, suggesting features of early muscle differentiation, without ruling out a myofibroblastic origin. Focal cavity lining of non-synovial flat or raised cells (CD34/CD31/CD10/E-cadherin-negative and podoplanin-positive in 34% of cases) was detected in 93% of cases, showing differential expression with synovial membrane and scapholunate ligament cells. Nuclear positivity for proliferative markers was observed in GC wall cells (258.1±255; 1019.3±316 positive cells/mm², Ki-67 and PCNA, respectively) but positivity for these markers was significantly lower (p⟨0.001 Mann Whitney U-test) in scapholunate ligament samples. CONCLUSION: In this first immunohistochemical study of GCs, focal cellular lining of the cavity was observed in almost all cases, and the immunophenotype was identical to that of GC wall cells. These cells are immunohistochemically different from synoviocytes and scapholunate ligament cells and show characteristics of myofibroblasts or mesenchymal cells undergoing early muscle differentiation.


Subject(s)
Ganglion Cysts/metabolism , Ganglion Cysts/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Cell Differentiation , Child , Child, Preschool , Cross-Sectional Studies , Female , Ganglion Cysts/etiology , Humans , Immunohistochemistry , Joint Capsule/metabolism , Joint Capsule/pathology , Ligaments/metabolism , Ligaments/pathology , Male , Middle Aged , Myofibroblasts/metabolism , Myofibroblasts/pathology , Stress, Mechanical , Synovial Membrane/metabolism , Synovial Membrane/pathology , Young Adult
6.
ScientificWorldJournal ; 2013: 486574, 2013.
Article in English | MEDLINE | ID: mdl-24319370

ABSTRACT

We test the hypothesis that PARP inhibition can decrease acute tubular necrosis (ATN) and other renal lesions related to prolonged cold ischemia/reperfusion (IR) in kidneys preserved at 4°C in University of Wisconsin (UW) solution. Material and Methods. We used 30 male Parp1(+/+) wild-type and 15 male Parp1(0/0) knockout C57BL/6 mice. Fifteen of these wild-type mice were pretreated with 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ) at a concentration of 15 mg/kg body weight, used as PARP inhibitor. Subgroups of mice were established (A: IR 45 min/6 h; B: IR + 48 h in UW solution; and C: IR + 48 h in UW solution plus DPQ). We processed samples for morphological, immunohistochemical, ultrastructural, and western-blotting studies. Results. Prolonged cold ischemia time in UW solution increased PARP-1 expression and kidney injury. Preconditioning with PARP inhibitor DPQ plus DPQ supplementation in UW solution decreased PARP-1 nuclear expression in renal tubules and renal damage. Parp1(0/0) knockout mice were more resistant to IR-induced renal lesion. In conclusion, PARP inhibition attenuates ATN and other IR-related renal lesions in mouse kidneys under prolonged cold storage in UW solution. If confirmed, these data suggest that pharmacological manipulation of PARP activity may have salutary effects in cold-stored organs at transplantation.


Subject(s)
Ischemia/pathology , Kidney/blood supply , Poly(ADP-ribose) Polymerase Inhibitors , Reperfusion Injury/prevention & control , Animals , Blotting, Western , Cold Temperature , Isoquinolines/pharmacology , Kidney/pathology , Kidney/ultrastructure , Kidney Tubular Necrosis, Acute/pathology , Kidney Tubular Necrosis, Acute/prevention & control , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Electron , Piperidines/pharmacology , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/physiology , Reperfusion Injury/pathology
7.
Biomed Res Int ; 2013: 629235, 2013.
Article in English | MEDLINE | ID: mdl-23984391

ABSTRACT

The development, growth, and function of the prostate gland depend on androgen stimulation. The primary androgen in prostate is 5α-dihydrotestosterone (DHT) which is synthesized from circulating testosterone (T) through the action of 5α-reductase (5α-R). Although 5α-R occurs as five isozymes, only 5α-R1 and 5α-R2 are physiologically involved in steroidogenesis. The endocrine disruptor bisphenol A (BPA) alters sexual organs, including the prostate. Our previous findings indicated that BPA decreased the expression of 5α-R1 and 5α-R2 in rat prostate but also circulating T. Thus, it is unclear whether BPA exerts this effect on 5α-R isozymes by reducing circulating T or by any other mechanism. In this study, we examine the effects of short-term exposure to BPA at doses below 25 µg/Kg/d and above 300 µg/Kg/d of the TDI on mRNA levels of 5α-R1 and 5α-R2 in prostate of adult castrated rats supplemented with T to achieve constant circulating T levels. mRNA levels were measured by absolute quantitative RT-PCR, T levels by RIA, and DHT levels by ELISA. Our results indicated that in castrated rats treated with T BPA at the two doses studied significantly decreased the mRNA levels of both 5α-R isozymes in a dose-dependent manner without modifications in circulating T.


Subject(s)
Benzhydryl Compounds/toxicity , Cholestenone 5 alpha-Reductase/metabolism , Phenols/toxicity , Prostate/drug effects , Prostate/enzymology , Testosterone/pharmacology , Animals , Castration , Cholestenone 5 alpha-Reductase/genetics , Dihydrotestosterone/blood , Gene Expression Regulation, Enzymologic/drug effects , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Organ Size/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Testosterone/blood
8.
PLoS Genet ; 9(6): e1003531, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23785295

ABSTRACT

PARP inhibition can induce anti-neoplastic effects when used as monotherapy or in combination with chemo- or radiotherapy in various tumor settings; however, the basis for the anti-metastasic activities resulting from PARP inhibition remains unknown. PARP inhibitors may also act as modulators of tumor angiogenesis. Proteomic analysis of endothelial cells revealed that vimentin, an intermediary filament involved in angiogenesis and a specific hallmark of EndoMT (endothelial to mesenchymal transition) transformation, was down-regulated following loss of PARP-1 function in endothelial cells. VE-cadherin, an endothelial marker of vascular normalization, was up-regulated in HUVEC treated with PARP inhibitors or following PARP-1 silencing; vimentin over-expression was sufficient to drive to an EndoMT phenotype. In melanoma cells, PARP inhibition reduced pro-metastatic markers, including vasculogenic mimicry. We also demonstrated that vimentin expression was sufficient to induce increased mesenchymal/pro-metastasic phenotypic changes in melanoma cells, including ILK/GSK3-ß-dependent E-cadherin down-regulation, Snail1 activation and increased cell motility and migration. In a murine model of metastatic melanoma, PARP inhibition counteracted the ability of melanoma cells to metastasize to the lung. These results suggest that inhibition of PARP interferes with key metastasis-promoting processes, leading to suppression of invasion and colonization of distal organs by aggressive metastatic cells.


Subject(s)
Breast Neoplasms/genetics , Cell Transformation, Neoplastic/genetics , Melanoma, Experimental/genetics , Poly(ADP-ribose) Polymerases/genetics , Vimentin , Animals , Antigens, CD/genetics , Antigens, CD/metabolism , Breast Neoplasms/pathology , Cadherins/genetics , Cadherins/metabolism , Cell Line, Tumor , Dogs , Endothelial Cells/metabolism , Epithelial-Mesenchymal Transition/genetics , Female , Gene Expression Regulation, Neoplastic , Human Umbilical Vein Endothelial Cells , Humans , MCF-7 Cells , Melanoma, Experimental/pathology , Mice , Neoplasm Invasiveness/genetics , Neoplasm Metastasis , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerase Inhibitors , Vimentin/genetics , Vimentin/metabolism
9.
Brain Behav Immun ; 30: 54-60, 2013 May.
Article in English | MEDLINE | ID: mdl-23376169

ABSTRACT

Ghrelin is an important gastrointestinal hormone that regulates feeding and metabolism. Moreover, ghrelin is produced by immune cells and shows potent anti-inflammatory activities. Here, we investigated its effect in two models of experimental autoimmune encephalomyelitis (EAE) that mirror chronic and relapsing-remitting multiple sclerosis. A short systemic treatment with ghrelin after the disease onset reduced clinical severity and incidence of both forms of EAE, which was associated with a decrease in inflammatory infiltrates in spinal cord and in the subsequent demyelination. This therapeutic effect was exerted through the reduction of the autoimmune and inflammatory components of the disease. Ghrelin decreased the presence/activation of encephalitogenic Th1 and Th17 cells in periphery and nervous system, down-regulated various inflammatory mediators, and induced regulatory T cells. In summary, our findings provide a powerful rationale for the assessment of the efficacy of ghrelin as a novel therapeutic approach for treating multiple sclerosis through distinct immunomodulatory mechanisms and further support the concept that the neuroendocrine and immune systems crosstalk to finely tune the final immune response of our body.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/drug therapy , Ghrelin/therapeutic use , T-Lymphocytes, Regulatory/drug effects , Th1 Cells/drug effects , Th17 Cells/drug effects , Animals , Cytokines/metabolism , Down-Regulation/drug effects , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/metabolism , Forkhead Transcription Factors/metabolism , Ghrelin/pharmacology , Inflammation/drug therapy , Inflammation/immunology , Inflammation/metabolism , Mice , Spinal Cord/drug effects , Spinal Cord/immunology , Spinal Cord/metabolism , T-Lymphocytes, Regulatory/immunology , Th1 Cells/immunology , Th1 Cells/metabolism , Th17 Cells/immunology , Th17 Cells/metabolism
10.
PLoS One ; 8(2): e55905, 2013.
Article in English | MEDLINE | ID: mdl-23405234

ABSTRACT

The high incidence of prostate cancer (PCa) and benign prostatic hypertrophy (BPH) in elderly men is a cause of increasing public health concern. In recent years, various environmental endocrine disruptors, such as bisphenol A (BPA), have been shown to disrupt sexual organs, including the prostate gland. However, the mechanisms underlying these effects remain unclear. Because androgens and estrogens are important factors in prostate physiopathology, our objective was to examine in rat ventral prostate the effects of adult exposure to BPA on 5α-Reductase isozymes (5α-R types 1, 2, and 3) and aromatase, key enzymes in the biosynthesis of dihydrotestosterone and estradiol, respectively. Adult rats were subcutaneously injected for four days with BPA (25, 50, 300, or 600 µg/Kg/d) dissolved in vehicle. Quantitative RT-PCR, western blot and immunohistochemical analyses showed lower mRNA and protein levels of 5α-R1 and 5α-R2 in BPA-treated groups versus controls but higher mRNA levels of 5α-R3, recently proposed as a biomarker of malignancy. However, BPA treatment augmented mRNA and protein levels of aromatase, whose increase has been described in prostate diseases. BPA-treated rats also evidenced a higher plasma estradiol/testosterone ratio, which is associated with prostate disease. Our results may offer new insights into the role of BPA in the development of prostate disease and may be of great value for studying the prostate disease risk associated with exposure to BPA in adulthood.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Aromatase/metabolism , Benzhydryl Compounds/pharmacology , Estrogens, Non-Steroidal/pharmacology , Membrane Proteins/metabolism , Phenols/pharmacology , Prostate/metabolism , Prostatic Hyperplasia/metabolism , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Animals , Aromatase/genetics , Blotting, Western , Estradiol/blood , Immunoenzyme Techniques , Isoenzymes , Male , Membrane Proteins/genetics , Prostate/drug effects , Prostatic Hyperplasia/drug therapy , Prostatic Hyperplasia/genetics , RNA, Messenger/genetics , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Testosterone/blood
11.
FEBS J ; 280(1): 93-101, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23122426

ABSTRACT

The elevated incidence of prostate cancer and benign prostatic hypertrophy is a cause of increasing public health concern in the Western world. The normal and pathological growth of the prostate are both dependent on stimulation by dihydrotestosterone, which is synthesized from circulating testosterone by two 5α-reductase (5α-R) isozymes, 5α-reductase type 1 (5α-R1) and 5α-reductase type 2 (5α-R2). Both isozymes have been implicated in prostate disease. We used quantitative RT-PCR and immunohistochemistry, respectively, to quantify mRNA and protein levels of 5α-R isozymes in the ventral prostate of adult rats under environmental stress conditions analogous to those found in some common workplace situations, i.e. artificial light, excessive heat, and the sensation of immobility in a small space. Transcription and expression levels of both 5α-R isozymes were significantly higher in environmentally stressed rats than in unstressed rats. Increased 5α-R isozyme levels may play a role in the development or maintenance of prostate disease. Further research is warranted to explore these effects of environmental stress on human health and their implications for environmental and occupational health policies.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Membrane Proteins/metabolism , Prostate/enzymology , Stress, Psychological/enzymology , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Adrenocorticotropic Hormone/blood , Animals , Corticosterone/blood , Dihydrotestosterone/metabolism , Gene Expression , Gene Expression Regulation, Enzymologic , Hot Temperature , Isoenzymes/genetics , Isoenzymes/metabolism , Lighting , Male , Membrane Proteins/genetics , Prolactin/blood , Prostate/metabolism , Rats , Rats, Wistar , Restraint, Physical , Stress, Physiological , Stress, Psychological/blood
12.
Hypertension ; 60(6): 1458-63, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23071124

ABSTRACT

We investigated the effects of uninephrectomy (UNX) in 6-week-old male and female rats on blood pressure (BP), renal sodium handling, salt sensitivity, oxidative stress, and renal injury over 18 months postsurgery, studying control sham-operated and UNX-operated rats at 6, 12, and 18 months postsurgery, evaluating their renal sodium handling, BP, urinary isoprostanes, N-acetyl-ß-D-glucosaminidase, and proteinuria before and after a 2-week high-salt intake period. At 18 months, plasma variables were measured and kidney samples were taken for the analysis of renal morphology and tissue variables. BP was increased at 6 months in male UNX rats versus controls and at 12 and 18 months in both male and female UNX rats and was increased in male versus female UNX groups at 18 months. UNX did not affect water and sodium excretion under basal conditions and after the different test in male and female rats at different ages. However, the renal function curve was shifted to the right in both male and female UNX rats. High-salt intake increased BP in both UNX groups at 6, 12, and 18 months and in the female control group at 18 months, and it increased proteinuria, N-acetyl-ß-D-glucosaminidase, and isoprostanes in both UNX groups throughout the study. Renal lesions at 18 months were more severe in male versus female UNX rats. In summary, long-term UNX increased the BP, creatinine, proteinuria, pathological signs of renal injury, and salt sensitivity. Earlier BP elevation was observed and morphological lesions were more severe in male than in female UNX rats.


Subject(s)
Blood Pressure/physiology , Kidney/metabolism , Nephrectomy/methods , Oxidative Stress/physiology , Sodium/metabolism , Animals , Female , Kidney/pathology , Kidney/physiology , Kidney/surgery , Male , Proteinuria/metabolism , Proteinuria/pathology , Proteinuria/physiopathology , Rats , Rats, Wistar , Sex Factors
13.
IUBMB Life ; 64(1): 81-6, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22131296

ABSTRACT

Testosterone (T) plays an important role in developing brain, dictating sex-specific behavior and physiology. 3α,5α-Reduced neurosteroids also regulate reproductive behavior. The key enzyme in the biosynthesis of these neurosteroids is 5α-reductase (5α-R), expressed as two isozymes, 5α-R1 and 5α-R2. In this study, T and sesame oil (vehicle) were administered during postnatal sexual differentiation of the central nervous system (CNS) and mRNA levels of 5α-R isozymes, were measured using quantitative RT-PCR in prefrontal cortex of male and female rats with different androgenic status at adulthood. Our results indicate that T concentrations during postnatal sexual differentiation of the rat CNS, among other sex-dependent factors, influence brain levels of 5α-R isozymes in adulthood and the pattern of their regulation by androgen hormones.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Prefrontal Cortex/enzymology , Testosterone/physiology , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Animals , Animals, Newborn , Female , Gene Expression , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Prefrontal Cortex/drug effects , Prefrontal Cortex/growth & development , Prefrontal Cortex/metabolism , Rats , Rats, Wistar , Sex Characteristics , Testosterone/pharmacology
14.
PLoS One ; 4(9): e7138, 2009 Sep 28.
Article in English | MEDLINE | ID: mdl-19784367

ABSTRACT

UNLABELLED: Cold ischemia time especially impacts on outcomes of expanded-criteria donor (ECD) transplantation. Ischemia-reperfusion (IR) injury produces excessive poly[ADP-Ribose] Polymerase-1 (PARP-1) activation. The present study explored the hypothesis that increased tubular expression of PARP-1 contributes to delayed renal function in suboptimal ECD kidney allografts and in non-ECD allografts that develop posttransplant acute tubular necrosis (ATN). MATERIALS AND METHODS: Nuclear PARP-1 immunohistochemical expression was studied in 326 paraffin-embedded renal allograft biopsies (193 with different degrees of ATN and 133 controls) and in murine Parp-1 knockout model of IR injury. RESULTS: PARP-1 expression showed a significant relationship with cold ischemia time (r coefficient = 0.603), time to effective diuresis (r = 0.770), serum creatinine levels at biopsy (r = 0.649), and degree of ATN (r = 0.810) (p = 0.001, Pearson test). In the murine IR model, western blot showed an increase in PARP-1 that was blocked by Parp-1 inhibitor. Immunohistochemical study of PARP-1 in kidney allograft biopsies would allow early detection of possible delayed renal function, and the administration of PARP-1 inhibitors may offer a therapeutic option to reduce damage from IR in donor kidneys by preventing or minimizing ATN. In summary, these results suggest a pivotal role for PARP-1 in the ATN of renal transplantation. We propose the immunohistochemical assessment of PARP-1 in kidney allograft biopsies for early detection of a possible delayed renal function.


Subject(s)
Ischemia/pathology , Kidney Transplantation/methods , Kidney Tubules/pathology , Kidney/pathology , Necrosis/pathology , Poly(ADP-ribose) Polymerases/biosynthesis , Acute Disease , Animals , Biopsy , Cold Temperature , Humans , Immunohistochemistry/methods , Kidney Function Tests , Kidney Transplantation/adverse effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout
15.
Neuroreport ; 20(1): 93-6, 2009 Jan 07.
Article in English | MEDLINE | ID: mdl-18978642

ABSTRACT

Prolactin and 3alpha, 5alpha-reduced neurosteroids are implicated in maternal behavior. Sulpiride, an inductor of hyperprolactinemia, increased mRNA levels of 5alpha-reductase (5alpha-R), the key enzyme in the biosynthesis of these neurosteroids, indicating a possible interrelationship between prolactin levels and 5alpha-R, although the effects of sulpiride per se cannot be ruled out. In this study, we quantified mRNA levels of both 5alpha-R isozymes in prefrontal cortex of rats after the administration of metoclopramide, another inductor of prolactin secretion. The mRNA levels of both 5alpha-R isozymes were significantly increased in male and female rats by metoclopramide, although the effect was not identical to that of sulpiride. Therefore, other factors induced by these drugs, besides prolactin, may intervene in the regulation of both 5alpha-R isozymes.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Metoclopramide/pharmacology , Prefrontal Cortex/drug effects , Prolactin/blood , Animals , Dopamine Antagonists/administration & dosage , Dopamine Antagonists/pharmacology , Enzyme-Linked Immunosorbent Assay , Female , Gene Expression Regulation, Enzymologic/drug effects , Injections, Intraperitoneal , Isoenzymes/genetics , Linear Models , Male , Metoclopramide/administration & dosage , Prefrontal Cortex/enzymology , Prefrontal Cortex/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction
16.
IUBMB Life ; 60(1): 68-72, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18379994

ABSTRACT

Prolactin (PRL) is implicated in prostate growth and in the development and regulation of benign prostatic hypertrophy (BPH) and prostate cancer (PCa). PRL may exert its effects on prostate in synergism with androgens. The most active androgen in the prostate is the 5alpha-dihydrotestosterone (DHT) obtained from testosterone by the 5alpha-reductase (5alpha-R) enzyme, which is expressed in the prostate as two isozymes, 5alpha-R1 and 5alpha-R2. In this study, sulpiride, a prolactin-secretion inductor, was administered to male rats. mRNA levels of 5alpha-R1 and 5alpha-R2 were measured in prostate of controls and sulpiride-treated rats, using one-step quantitative RT-PCR coupled with laser-induced fluorescence capillary electrophoresis (LIF-CE). Results demonstrated that sulpiride-induced hyperprolactinemia is associated with an increase in mRNA levels of both 5alpha-R1 and 5alpha-R2 in prostate of adult rats. Although a direct effect of sulpiride on prostate gland cannot be ruled out, hyperprolactinemia may be a factor to be considered in aging males, in whom prostatic diseases such as BPH and PCa are more frequent.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Prostate/enzymology , RNA, Messenger/metabolism , Sulpiride/pharmacology , Animals , Hyperprolactinemia/chemically induced , Hyperprolactinemia/metabolism , Isoenzymes/metabolism , Male , Prolactin/blood , RNA, Messenger/drug effects , Rats
17.
Neurochem Res ; 33(5): 820-5, 2008 May.
Article in English | MEDLINE | ID: mdl-17940878

ABSTRACT

Prolactin (PRL) promotes maternal behavior (MB), a complex pattern of behavior aimed at maximizing offspring survival. 3alpha,5alpha-reduced neurosteroids may also regulate MB. Indeed, PRL, 3alpha,5alpha-reduced neurosteroids, and 5alpha-reductase (5alpha-R), the key enzyme in the biosynthesis of these neuroactive steroids, are all increased in stress situations These facts led us to hypothesize a possible interrelation between PRL levels and 5alpha-R. In the present study we quantified mRNA levels of both 5alpha-R isozymes in prefrontal cortex of male and female rats after administration of sulpiride, an inductor of PRL secretion. Our results demonstrated that mRNA levels of both 5alpha-R isozymes were significantly increased in male and female rats by sulpiride, directly or via sulpiride-induced hyperprolactinemia. Since 3alpha,5alpha-reduced neurosteroids and PRL exert anxiolytic effects in response to stress, these molecules and 5alpha-R may possibly participate in a common pathway of significant adaptation to stress situations.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Frontal Lobe/drug effects , Isoenzymes/genetics , Prolactin/blood , RNA, Messenger/genetics , Sulpiride/pharmacology , Animals , Female , Frontal Lobe/enzymology , Frontal Lobe/metabolism , Male , Polymerase Chain Reaction , Rats , Rats, Wistar
18.
Ann Rheum Dis ; 66(5): 582-8, 2007 May.
Article in English | MEDLINE | ID: mdl-17151007

ABSTRACT

BACKGROUND: Rheumatoid arthritis is a chronic autoimmune disease of unknown aetiology characterised by chronic inflammation in the joints and subsequent destruction of the cartilage and bone. AIM: To propose a new strategy for the treatment of arthritis based on the administration of cortistatin, a newly discovered neuropeptide with anti-inflammatory actions. METHODS: DBA/1J mice with collagen-induced arthritis were treated with cortistatin after the onset of disease, and the clinical score and joint histopathology were evaluated. Inflammatory response was determined by measuring the levels of various inflammatory mediators (cytokines and chemokines) in joints and serum. T helper cell type 1 (Th1)-mediated autoreactive response was evaluated by determining the proliferative response and cytokine profile of draining lymph node cells stimulated with collagen and by assaying the content of serum autoantibodies. RESULTS: Cortistatin treatment significantly reduced the severity of established collagen-induced arthritis, completely abrogating joint swelling and destruction of cartilage and bone. The therapeutic effect of cortistatin was associated with a striking reduction in the two deleterious components of the disease-that is, the Th1-driven autoimmune and inflammatory responses. Cortistatin downregulated the production of various inflammatory cytokines and chemokines, decreased the antigen-specific Th1-cell expansion, and induced the production of regulatory cytokines, such as interleukin 10 and transforming growth factor beta1. Cortistatin exerted its effects on synovial cells through both somatostatin and ghrelin receptors, showing a higher effect than both peptides protecting against experimental arthritis. CONCLUSION: This work provides a powerful rationale for the assessment of the efficacy of cortistatin as a novel therapeutic approach to the treatment of rheumatoid arthritis.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Arthritis, Experimental/drug therapy , Neuropeptides/therapeutic use , Th1 Cells/immunology , Animals , Anti-Inflammatory Agents/immunology , Arthritis, Experimental/immunology , Collagen Type II/immunology , Cytokines/drug effects , Cytokines/immunology , Disease Models, Animal , Dose-Response Relationship, Drug , Down-Regulation/immunology , Immunoglobulins/blood , Mice , Mice, Inbred DBA , Neuropeptides/immunology , Receptors, G-Protein-Coupled/immunology , Receptors, Ghrelin , Receptors, Somatostatin/immunology , Severity of Illness Index , Synovial Membrane/immunology , Synovial Membrane/pathology , Treatment Outcome
19.
Am J Dermatopathol ; 26(3): 237-41, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15166515

ABSTRACT

This report describes the clinicopathologic, immunohistochemical, and ultrastructural features of a benign fibrous histiocytoma of 3 years' duration situated on the posterior right arm of a 17-year-old woman. To our knowledge, this is the first published description of an association between the histologic features of benign fibrous histiocytoma with proliferating dermal dendrocytes and solid clusters of indeterminate cells and inflammatory infiltrate containing numerous eosinophils. Cell type identification was confirmed by immunohistochemical demonstration of positivity of indeterminate cells for CD1a and S-100 protein, by absence of Birbeck granules in electron microscopy study, and by positivity of fibroblast-like cells for factor XIIIa and negativity for CD34. Mitosis or cytologically atypical cells were absent. The MIB1-measured proliferative index of the tumor cells was less than 5% in spindle cells and approximately 15% in indeterminate cells. Possible pathogenic pathways are discussed that could account for divergent differentiation or a combination of neoplasms of different lineages.


Subject(s)
Eosinophils/pathology , Histiocytoma, Benign Fibrous/pathology , Neoplasms, Second Primary/diagnosis , Skin Neoplasms/pathology , Adolescent , Antigens, CD1/analysis , Biomarkers, Tumor/analysis , Cell Nucleus/ultrastructure , Cytoplasm/ultrastructure , Dendritic Cells/pathology , Dermis/pathology , Diagnosis, Differential , Factor XIIIa/analysis , Female , Histiocytoma, Benign Fibrous/chemistry , Histiocytoma, Benign Fibrous/surgery , Humans , Insect Bites and Stings/diagnosis , Pseudolymphoma/diagnosis , S100 Proteins/analysis , Skin Neoplasms/chemistry , Skin Neoplasms/surgery
20.
Am J Hypertens ; 16(1): 33-8, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12517680

ABSTRACT

BACKGROUND: This study investigates the effects of chronic administration of omapatrilat (OMA) on blood pressure (BP), renal injury, and other variables in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension and in the low-renin model produced by the simultaneous administration of L-NAME and deoxycorticosterone acetate (DOCA). METHODS: The control, DOCA, L-NAME, L-NAME + DOCA, L-NAME + OMA, and L-NAME + DOCA + OMA groups were used. Tail systolic BP was measured twice a week. After 4 weeks of treatment, mean arterial pressure (MAP), and metabolic, morphologic, and renal variables were measured. RESULTS: The final values of MAP were 109 +/- 5.1 mm Hg for the control group, 113 +/- 3.0 mm Hg for DOCA, 175 +/- 3.7 mm Hg for L-NAME, 193 +/- 3.8 mm Hg for L-NAME + DOCA, 117 +/- 3.9 mm Hg for L-NAME + OMA, and 158 +/- 3.0 mm Hg for L-NAME + DOCA + OMA. The rats treated with L-NAME showed mild and scarce renal lesions, which were prevented by OMA treatment and the L-NAME + DOCA group showed proteinuria and hyaline arteriopathy, which were markedly attenuated in the L-NAME + DOCA + OMA group. Plasma urea and creatinine were significantly increased in the L-NAME + DOCA group, whereas these variables were not significantly greater in the L-NAME + DOCA + OMA group versus controls. The L-NAME + DOCA group showed relative renal and cardiac hypertrophy that was not observed in the L-NAME + DOCA + OMA group. CONCLUSIONS: The simultaneous blockade of neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE) completely prevents L-NAME hypertension. Our results also show that OMA attenuates the increased BP and the renal injury in L-NAME hypertensive rats treated with DOCA. Assuming that this is a low-renin model of hypertension, the protective effect of OMA may be due to an increase in vasodilator peptides produced by both ACE and NEP inhibition.


Subject(s)
Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Hypertension, Renal/drug therapy , Pyridines/pharmacology , Thiazepines/pharmacology , Animals , Body Weight , Creatinine/blood , Desoxycorticosterone , Disease Models, Animal , Drinking/drug effects , Eating/drug effects , Enzyme Inhibitors , Hypertension, Renal/chemically induced , Hypertension, Renal/pathology , Kidney/pathology , Male , NG-Nitroarginine Methyl Ester , Natriuresis/drug effects , Potassium/blood , Rats , Rats, Wistar , Sodium/blood , Urea/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...